HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
ENGIN News & Announcements
Displaying announcements from the past three years.
1 - 26 of 26
Our research news roundup highlights newly approved gene therapies, insights into common genetic epilepsy disorders, and head injury prevention for young athletes.
This major step allows for the creation of clinical trials to test key endpoints that will determine the efficacy of new therapies.
An experimental compound might be further developed as an effective treatment approach for affected patients.
Dravet syndrome is a severe neurodevelopmental disorder defined by treatment-resistant epilepsy and features related to autism spectrum disorder.
Learn about a technique to analyze large datasets, preclinical results that show safety and efficacy of a drug that could help children with high-risk neuroblastoma, and a milestone in the CORSICA project that seeks to cure rare sinonasal cancers.
In this news roundup, learn how CHOP researchers are advancing research for neurological diseases and engaging in community collaborative research.
An update on the milestones reached to advance pediatric brain tumor research, driving forward the efforts of CHOP’s Neuroscience Center.
This week's news roundup features an outstanding science award, Highly Cited Researchers, and STAT Wunderkinds, along with new research about cancer risk with birth defects, epilepsy, and acute myeloid leukemia.
Patients with the identified variant may respond favorably to targeted treatment with a readily available anti-seizure medication.
Learn about novel findings and new grants from Children’s Hospital of Philadelphia researchers.
Dr. Goldberg studies how genetic variation in ion channels leads to underlying brain circuit dysfunction in epilepsy and other disorders.
Dr. Ethan Goldberg received a new grant and published a paper, both focusing on the role of ion channels and genes in epileptic disorders.
This week in the news: a pediatric cancer summit, early diagnosis of Leigh Syndrome, quality of life in severe epilepsy, and more.
Study shows quality of life is strongly associated with the number of days minimally disrupted by seizures rather than seizure frequency alone.
Drs. Kessler and Kennedy gave presentations as part of the Epilepsy Foundation of Eastern Pennsylvania’s series for Epilepsy Awareness Month.
Researchers determined that capturing standardized clinical data helps predict seizure burden and classify type of epilepsy disorder.
Major improvements are made to a framework that seeks to standardize clinical descriptions of epilepsy used for computational analysis.
This week’s research news features Kathrin Bernt, MD, and Richard Aplenc, MD, PhD, MSCE, recipients of Children’s Cancer Research Fund Awards.
This week’s roundup features CHOP’s participation in a multi-institutional MIS-C research study — the first to provide long-term outcome data.
This week’s roundup features research exploring the value of well care as voiced by Black adolescent males and their parents. This and more In The News.
By standardizing how clinical information is analyzed, researchers found 11 causative genes associated with specific symptoms.
Researchers from CHOP linked genetic information to electronic medical records to study how genetic neurological disorders in children develop over time.
Genetic cause of rare form of childhood epilepsy, Febrile infection-related epilepsy syndrome (FIRES), remains unknown.
Division of Neurology researchers set out to discover whether newly implemented audio-video telemedicine visits are an effective way of delivering care.
This week’s In the News features studies on RNA’s role in epilepsy, missed opportunities in HIV Testing, and a Leadership Award for Dr. St. Geme.
The Epilepsy NeuroGenetics Initiative is bridging the gap between advances in genetic discovery and improvements in treatment.